Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011.

Kapoor DA, Bostwick DG, Mendrinos SE, Anderson AE, Olsson CA.

Rev Urol. 2013;15(4):137-44.

PMID:
24659910
[PubMed]
Free PMC Article
2.

Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

Orozco R, O'Dowd G, Kunnel B, Miller MC, Veltri RW.

Urology. 1998 Feb;51(2):186-95. Erratum in: Urology 1998 Mar;51(3):523.

PMID:
9495696
[PubMed - indexed for MEDLINE]
3.

Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?

Rubin MA, Bismar TA, Curtis S, Montie JE.

Am J Surg Pathol. 2004 Jul;28(7):946-52.

PMID:
15223967
[PubMed - indexed for MEDLINE]
4.

What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?

Descazeaud A, Rubin MA, Allory Y, Burchardt M, Salomon L, Chopin D, Abbou C, de la Taille A.

Eur Urol. 2005 Dec;48(6):911-5. Epub 2005 Aug 9.

PMID:
16140457
[PubMed - indexed for MEDLINE]
5.

Adequate histologic sectioning of prostate needle biopsies.

Bostwick DG, Kahane H.

Ann Diagn Pathol. 2013 Aug;17(4):357-60. doi: 10.1016/j.anndiagpath.2013.04.006. Epub 2013 Jun 10.

PMID:
23764163
[PubMed - in process]
6.

Urologists' self-referral for pathology of biopsy specimens linked to increased use and lower prostate cancer detection.

Mitchell JM.

Health Aff (Millwood). 2012 Apr;31(4):741-9. doi: 10.1377/hlthaff.2011.1372.

PMID:
22492891
[PubMed - indexed for MEDLINE]
7.

Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.

Epstein JI, Herawi M.

J Urol. 2006 Mar;175(3 Pt 1):820-34. Review.

PMID:
16469560
[PubMed - indexed for MEDLINE]
8.

Is race a positive predictor of cancer on repeat prostate biopsy?

Yanke BV, Salzhauer EW, Colon I.

J Urol. 2006 Sep;176(3):1114-7.

PMID:
16890704
[PubMed - indexed for MEDLINE]
9.

Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.

Borboroglu PG, Sur RL, Roberts JL, Amling CL.

J Urol. 2001 Sep;166(3):866-70. Review.

PMID:
11490235
[PubMed - indexed for MEDLINE]
10.

Prediction of tumour volume and pathological stage in radical prostatectomy specimens is not improved by taking more prostate needle-biopsy cores.

Grossklaus DJ, Coffey CS, Shappell SB, Jack GS, Cookson MS.

BJU Int. 2001 Nov;88(7):722-6.

PMID:
11890243
[PubMed - indexed for MEDLINE]
11.

Needle core length in sextant biopsy influences prostate cancer detection rate.

Iczkowski KA, Casella G, Seppala RJ, Jones GL, Mishler BA, Qian J, Bostwick DG.

Urology. 2002 May;59(5):698-703.

PMID:
11992843
[PubMed - indexed for MEDLINE]
12.

The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.

Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M, Magi-Galluzzi C.

BJU Int. 2007 Apr;99(4):770-4. Epub 2007 Jan 16.

PMID:
17233800
[PubMed - indexed for MEDLINE]
13.

Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer.

Taylor JA 3rd, Gancarczyk KJ, Fant GV, Mcleod DG.

Urology. 2002 Nov;60(5):841-5.

PMID:
12429312
[PubMed - indexed for MEDLINE]
14.

Sampling, submission, and report format for multiple prostate biopsies: a 1999 survey.

Iczkowski KA, Bostwick DG.

Urology. 2000 Apr;55(4):568-71.

PMID:
10736505
[PubMed - indexed for MEDLINE]
15.

Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy.

Kestin LL, Goldstein NS, Vicini FA, Mitchell C, Gustafson GS, Stromberg JS, Chen PY, Martinez AA.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):107-18.

PMID:
12182980
[PubMed - indexed for MEDLINE]
16.

[Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].

Damiano R, Oliva A, Cantiello F, Esposito C, Perdonà S, De Sio M, Bitonti M, Sacco R, D'Armiento M.

Arch Ital Urol Androl. 2003 Mar;75(1):40-5. Italian.

PMID:
12741345
[PubMed - indexed for MEDLINE]
17.

Use of immunohistochemistry in routine workup of prostate needle biopsies: a tertiary academic institution experience.

Watson K, Wang C, Yilmaz A, Bismar TA, Trpkov K.

Arch Pathol Lab Med. 2013 Apr;137(4):541-5. doi: 10.5858/arpa.2012-0145-OA. Epub 2012 Dec 28.

PMID:
23273390
[PubMed - indexed for MEDLINE]
18.

Pathologic features the urologist should expect on a prostate biopsy.

Che M, Sakr W, Grignon D.

Urol Oncol. 2003 Mar-Apr;21(2):153-61. Review.

PMID:
12856645
[PubMed - indexed for MEDLINE]
19.

Current routines for transrectal ultrasound-guided prostate biopsy: a web-based survey by the Swedish Urology Network.

Carlsson S, Bratt O, Stattin P, Egevad L.

Scand J Urol Nephrol. 2012 Dec;46(6):405-10. doi: 10.3109/00365599.2012.691111. Epub 2012 May 31.

PMID:
22647198
[PubMed - indexed for MEDLINE]
20.

[Histopathology reports of findings of prostate needle biopsies. Individual treatment].

Damjanoski I, Müller J, Schnöller TJ, Küfer R, Rinnab L.

Urologe A. 2013 Feb;52(2):226-39. doi: 10.1007/s00120-012-3008-1. German.

PMID:
23064867
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk